The Relative Timing, Outcomes, and Economic Impact of Anti-Nuclear Antibody (ANA) and Extractable Nuclear Antigen (ENA) Laboratory Ordering

Clinical Medicine and Research · Published 2024-09-01 · DOI 10.3121/cmr.2024.1937

Authors being retrieved — see the publisher record. https://doi.org/10.3121/cmr.2024.1937

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2024

Related articles

• PRN Antihypertensives in Hospitals: A Crisis of Precision or Pragmatism? · Clinical Medicine and Research · 2025 · Same journal
• Comprehensive Statistical Approach to Investigate the Risk Factors Affecting the Occurrences of Cellulitis Episodes among Patients with Lymphedema · Clinical Medicine and Research · 2024 · Same journal
• Impaired Sustained Attention in Patients with Subclinical Hypothyroidism · Clinical Medicine and Research · 2025 · Same journal
• Cardiovascular Death and Liver Disease: Mortality Trends and Disparities · Clinical Medicine and Research · 2024 · Same journal
• Elderly at a Crossroads: Rehabilitation and Hospice Outcomes in Small Traumatic Brain Injuries · Clinical Medicine and Research · 2026 · Same journal
• Long COVID or Post-Acute Sequelae of COVID-19 (PASC) in Children and Adolescents · Clinical Medicine and Research · 2024 · Same journal
• Potential Application of Anti-Cyclic Citrullinated Peptide (Anti-CCP) for the Diagnosis of Periodontal Disease in Patients with Rheumatoid Arthritis with Cut-Off Determination · Clinical Medicine and Research · 2024 · Same journal
• Voriconazole-induced Hypoglycemia in a Non-diabetic Patient: A Rare Cause · Clinical Medicine and Research · 2025 · Same journal
• “Dialogue Between Franklin and the Gout” Reexamined · Clinical Medicine and Research · 2023 · Same journal
• COVID-19-Related Treatment Cancellations and Oncology Patients’ Psychological Health in Nigeria · Clinical Medicine and Research · 2024 · Same journal